These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 13387020

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effects of priscol (2-benzyl-4,5-imidazoline HCl) on peripheral vascular diseases, hypertension and circulation in patients.
    GRIMSON KS, REARDON MJ.
    Trans South Surg Assoc; ; 59 (1 vol.)():229-52. PubMed ID: 18105752
    [No Abstract] [Full Text] [Related]

  • 3. Clinical appraisal of a new adrenergic blocking agent: effect of regitine on digital blood flow in normal subjects and patients with peripheral arterial diseases.
    CLARKE CW, HAYS DR, VAN ITALLIE TB.
    Circulation; 1953 Nov; 8(5):715-22. PubMed ID: 13106893
    [No Abstract] [Full Text] [Related]

  • 4. VASCULAR AND ADRENERGIC BLOCKING ACTIONS OF SEVERAL SUBSTITUTED 2-AMINO IMIDAZOLINES.
    HUTCHEON DE, SCRIABINE A, LING JS, PAN SY, BLOOM BM.
    Arch Int Pharmacodyn Ther; 1964 Jan 01; 147():146-55. PubMed ID: 14116922
    [No Abstract] [Full Text] [Related]

  • 5. The effects of priscol (2-benzyl-4,5-imidazoline hydrochloride) in the treatment of peripheral vascular diseases.
    FRANK N, STRAZZA JA, HELSPER JT.
    Ann Intern Med; 1951 Jul 01; 35(1):19-38. PubMed ID: 14847446
    [No Abstract] [Full Text] [Related]

  • 6. Adrenolytic and sympatholytic actions of priscol (benzyl-imidazoline).
    CHESS D, YONKMAN FF.
    Proc Soc Exp Biol Med; 1946 Feb 01; 61():127-30. PubMed ID: 21017595
    [No Abstract] [Full Text] [Related]

  • 7. [Contribution to the study of a new sympatholytic substance, benzyl 2-imidazoline hydrochloride, priscol].
    SOLLERO L.
    Rev Med Cir Sao Paulo; 1948 Feb 01; 56(1-2):9-16. PubMed ID: 18874101
    [No Abstract] [Full Text] [Related]

  • 8. 2-Benzyl-imidazoline hydrochloride in hemiplegia.
    ANNAMALAI AL.
    J Indian Med Assoc; 1956 Jul 01; 27(1):5-6. PubMed ID: 13346106
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of priscolin (2-benzyl-4,5-imidazoline hydrochloride) on circulation and skin temperature in normal man.
    KAUGMAN J, IGLAUER A, HERWITZ GK.
    Angiology; 1950 Dec 01; 1(6):515-9. PubMed ID: 14790320
    [No Abstract] [Full Text] [Related]

  • 11. [Determination of circulation rate with sodium fluorescein in peripheral arterial diseases].
    VAS G, SZITA I, LENCZ L.
    Orv Hetil; 1955 Sep 25; 96(39):1081-4. PubMed ID: 13289036
    [No Abstract] [Full Text] [Related]

  • 12. Clinical experience with sympathetic blocking agents in peripheral vascular disease.
    MOSER M, PRANDONI AG, ORBISON JA, MATTINGLY TW.
    Ann Intern Med; 1953 Jun 25; 38(6):1245-64. PubMed ID: 13065974
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acrodynia treated with 2-benzyl-imidazoline hydrochloride.
    GILLESPIE AE.
    Can Med Assoc J; 1952 Nov 25; 67(5):418-21. PubMed ID: 13009581
    [No Abstract] [Full Text] [Related]

  • 16. The effect of priscoline on the clearance of radiosodium from muscle and skin of man in normal and diseased limbs.
    FREUND J, WISHAM LH, YALOW RS.
    Circulation; 1953 Jul 25; 8(1):89-97. PubMed ID: 13059867
    [No Abstract] [Full Text] [Related]

  • 17. [Blood circulation findings and general prognosis in obliterative arterial diseases].
    JAQUET GH, MEYER-BURGDORFF G.
    Thoraxchirurgie; 1962 Jul 25; 10():75-88. PubMed ID: 14451289
    [No Abstract] [Full Text] [Related]

  • 18. Observations of the effects of the autonomic blocking agent, bis-trimethylammonium pentane dibromide (C5) in normal subjects and in patients with peripheral vascular disease and hypertension, and comparison with tetraethylammonium chloride.
    GROB D, HARVEY M.
    Bull Johns Hopkins Hosp; 1950 Dec 25; 87(6):616-39. PubMed ID: 14783722
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ganglion-Blocking agents in mitral-valve disease.
    GOODWIN JF, HOLLMAN A, O'DONNELL TV.
    Lancet; 1958 Dec 13; 2(7059):1251-6. PubMed ID: 13612185
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.